TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 23248893

Group type: EXPERIMENTAL
Intervention: Multi-directional power toothbrush (Oral-B Vitality TriZone)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Manual toothbrush (ADA reference soft manual brush)
Number of subjects: 36
Study: 20447049

Group type: EXPERIMENTAL
Intervention: Botulinum toxin type A (BTA) injection combined with 10 sessions of physical and occupational therapy followed by 10 sessions of neuromuscular electrical stimulation on the wrist extensors
Number of subjects: 10
Study: 19192750

Group type: EXPERIMENTAL
Intervention: Modified ultrafiltration (MUF)
Number of subjects: 19

Group type: COMPARATOR
Intervention: No-MUF
Number of subjects: 19
Study: 15733028

Group type: EXPERIMENTAL
Intervention: Tibolone
Number of subjects: 4995

Group type: COMPARATOR
Intervention: Combined sequential HRT
Number of subjects: 4995
Study: 15562740

Group type: EXPERIMENTAL
Intervention: Pain tracker instrument
Number of subjects: 102

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 102
Study: 11078267

Group type: EXPERIMENTAL
Intervention: Young diabetic patients (yDM)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Older non-diabetic patients (o non-DM)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Young non-diabetic patients (y non-DM)
Number of subjects: 20
Study: 8985536

Group type: EXPERIMENTAL
Intervention: Pneumocystis carinii in AIDS patients
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Cytomegalovirus (CMV) in AIDS patients
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Pneumocystis carinii in symptomatic HIV infants
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Cytomegalovirus (CMV) in liver tissue from AIDS infants
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: CMV infections ante-mortem in AIDS patients
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Tuberculosis in post-mortem lung tissue
Number of subjects: 36
Study: 1335203

Group type: EXPERIMENTAL
Intervention: Phosphonoformate 3% drops
Number of subjects: 20

Group type: COMPARATOR
Intervention: Trifluorthymidine 1% drops
Number of subjects: 20
Study: 6363155

Group type: EXPERIMENTAL
Intervention: Arginine thiazolidinecarboxylate (800 mg/day for 40 days)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study: 31489424

Group type: EXPERIMENTAL
Intervention: Continuous oral health education
Number of subjects: 150

Group type: COMPARATOR
Intervention: Routine oral hygiene education (Control)
Number of subjects: 150
Study: 29858746

Group type: EXPERIMENTAL
Intervention: 10 kHz spinal cord stimulation (SCS)
Number of subjects: 171

Group type: COMPARATOR
Intervention: Traditional spinal cord stimulation (SCS)
Number of subjects: 171
Study: 27481881

Group type: EXPERIMENTAL
Intervention: Felodipine (10mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Coffee (2×300ml)
Number of subjects: 0
Study: 23488690

Group type: EXPERIMENTAL
Intervention: Simvastatin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Simvastatin + Losartan
Number of subjects: 0

Group type: COMPARATOR
Intervention: Losartan
Number of subjects: 0
Study: 23145844

Group type: EXPERIMENTAL
Intervention: Intervention
Number of subjects: 1433

Group type: COMPARATOR
Intervention: Control
Number of subjects: 1433
Study: 20519079

Group type: EXPERIMENTAL
Intervention: Yitongshu injection (4 ml) into the Zusanli point on both sides 11 hours or 23 hours after administration of the drugs.
Number of subjects: 28

Group type: COMPARATOR
Intervention: Midazolam combined with fentanyl (control group).
Number of subjects: 28
Study: 17425758

Group type: EXPERIMENTAL
Intervention: Amlodipine-enalapril combination
Number of subjects: 99

Group type: COMPARATOR
Intervention: Enalapril
Number of subjects: 99

Group type: COMPARATOR
Intervention: Amlodipine
Number of subjects: 99
Study: 15781019

Group type: EXPERIMENTAL
Intervention: Docosahexaenoic acid (1.2 g/day for 6 weeks)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 12217281

Group type: EXPERIMENTAL
Intervention: Catheter directed thrombolysis followed by anticoagulation
Number of subjects: 35

Group type: COMPARATOR
Intervention: Anticoagulation alone
Number of subjects: 35
Study: 10809859

Group type: EXPERIMENTAL
Intervention: Hypericum ointment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Solar-simulated radiation (SSR)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hyperforin (in vivo and in vitro)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hyperforin (in vitro)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hyperforin
Number of subjects: 0
Study: 9257602

Group type: EXPERIMENTAL
Intervention: Changed programme
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 1739365

Group type: EXPERIMENTAL
Intervention: buspirone
Number of subjects: 40

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 40
Study: 6433319

Group type: EXPERIMENTAL
Intervention: Heparin (1 U/mL) added to intravenous alimentation solutions
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group (no heparin)
Number of subjects: 26
Study: 31053295

Group type: EXPERIMENTAL
Intervention: Serum antibodies to neuronal proteins
Number of subjects: 50

Group type: COMPARATOR
Intervention: Healthy individuals (Control)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Seropositive status in patients with ME
Number of subjects: 50
Study: 30622487

Group type: EXPERIMENTAL
Intervention: Sprint Interval Training (SIT)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Continuous Aerobic Training (CAT)
Number of subjects: 50
Study: 28685542

Group type: EXPERIMENTAL
Intervention: Continuous blood purification (CBP) in addition to conventional therapy
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Continuous blood purification (CBP)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 120
Study: 26158927

Group type: EXPERIMENTAL
Intervention: HSM‐IOL (heparin surface modified intraocular lens)
Number of subjects: 102

Group type: COMPARATOR
Intervention: UC‐IOL (uncoated intraocular lens)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: HSM‐IOL
Number of subjects: 102

Group type: COMPARATOR
Intervention: UC‐IOL
Number of subjects: 102
Study: 23384411

Group type: EXPERIMENTAL
Intervention: Injection of human umbilical tissue-derived cells (hUTC) into the nucleus pulposus (NP)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Injection of hydrogel carrier alone
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Injection of human umbilical tissue-derived cells (hUTC) with hydrogel carrier
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Punctured group (no treatment)
Number of subjects: 30
Study: 21740403

Group type: EXPERIMENTAL
Intervention: Music therapy as an adjunct to pharmacological therapy
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (standard pharmacological therapy only)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Music therapy
Number of subjects: 60
Study: 18505387

Group type: EXPERIMENTAL
Intervention: AmB, 1 mg/kg per day, plus flucytosine, 25 mg/kg 4 times per day (group 2)
Number of subjects: 64

Group type: COMPARATOR
Intervention: AmB, 0.7 mg/kg per day, plus flucytosine, 25 mg/kg 4 times per day (group 1)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Both groups (group 1 and group 2)
Number of subjects: 64
Study: 17063641

Group type: EXPERIMENTAL
Intervention: Thyme-ivy combination syrup (5.4 ml three times daily for 11 days)
Number of subjects: 361

Group type: COMPARATOR
Intervention: Placebo syrup
Number of subjects: 361

Group type: EXPERIMENTAL
Intervention: Thyme-ivy combination syrup
Number of subjects: 361

Group type: COMPARATOR
Intervention: Thyme-ivy combination syrup and Placebo syrup
Number of subjects: 361
Study: 12953167

Group type: EXPERIMENTAL
Intervention: Low-dose radioiodine-131 (131I) treatment (141 +/- 85 MBq)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (spontaneous remission)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Thyroid volume at baseline and at 3 months
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Thyroid volume at 6 months
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Thyroid volume at 3 months
Number of subjects: 40
Study: 10782840

Group type: EXPERIMENTAL
Intervention: Low dose rhGH (12 IU/m2/week)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: High dose rhGH (24 IU/m2/week)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (age matched children)
Number of subjects: 20
Study: 9324342

Group type: COMPARATOR
Intervention: CVPP chemotherapy (3 cycles)
Number of subjects: 114

Group type: COMPARATOR
Intervention: CVPP chemotherapy (6 cycles)
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: CVPP chemotherapy (6 cycles) + Radiotherapy (RT)
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: AOPE chemotherapy (6 cycles) + Radiotherapy (RT)
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: CCOPP/CAPTe chemotherapy (6 cycles)
Number of subjects: 114
Study: 8223808

Group type: EXPERIMENTAL
Intervention: Acetaminophen administered at regular 4h intervals (group 1)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Sporadic usage of acetaminophen contingent upon a body temperature above 37.9 degrees C (group 2)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Sporadic usage of acetaminophen (group 2)
Number of subjects: 104
Study: 3950253

Group type: EXPERIMENTAL
Intervention: Terbutaline (0.25 mg per puff)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 30075954

Group type: EXPERIMENTAL
Intervention: Oestradiol 1.5 mg/day for 6 months
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Testosterone 50 mg/day for 6 months
Number of subjects: 26
Study: 27685254

Group type: EXPERIMENTAL
Intervention: IMPULS (impulsivity-focused group intervention)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 0
Study: 24909487

Group type: EXPERIMENTAL
Intervention: Magnesium oxide 450 mg up to three times daily
Number of subjects: 54

Group type: COMPARATOR
Intervention: No treatment (Control)
Number of subjects: 54
Study: 22105574

Group type: EXPERIMENTAL
Intervention: Family-oriented group program (15 sessions for parents and children)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Routine counselling (2 appointments for children)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Combined treatment arms
Number of subjects: 70
Study: 20839433

Group type: EXPERIMENTAL
Intervention: Microdiscectomy (Group A)
Number of subjects: 241

Group type: COMPARATOR
Intervention: Macrodiscectomy (Group B)
Number of subjects: 241
Study: 17925053

Group type: EXPERIMENTAL
Intervention: Mola (Amblypharyngodon mola), 600 retinol activity equivalents (RAE), 6 d/week for 9 weeks
Number of subjects: 196

Group type: COMPARATOR
Intervention: Rui (Labeo rohita) with added retinyl palmitate, 600 RAE, 6 d/week for 9 weeks
Number of subjects: 196

Group type: COMPARATOR
Intervention: Rui (Labeo rohita), 0 RAE, 6 d/week for 9 weeks
Number of subjects: 196
Study: 17220631

Group type: EXPERIMENTAL
Intervention: Duodenal orlistat with a fat-containing meal
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Oral orlistat
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Duodenal orlistat with a fat-free meal
Number of subjects: 0
Study: 12819524

Group type: EXPERIMENTAL
Intervention: Intervention condition
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard care condition
Number of subjects: 0
Study: 11122756

Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (PCI)
Number of subjects: 4

Group type: COMPARATOR
Intervention: Medical therapy
Number of subjects: 4
Study: 8784758

Group type: EXPERIMENTAL
Intervention: Aspirin (1.3 g) before running
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo (glucose) before running
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo (glucose) before rest
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Aspirin (1.3 g) before rest
Number of subjects: 7
Study: 7930385

Group type: EXPERIMENTAL
Intervention: Normal glucose tolerance subjects (n = 34)
Number of subjects: 430

Group type: COMPARATOR
Intervention: Nondiagnostic tolerance subjects (NDT, n = 30)
Number of subjects: 430

Group type: COMPARATOR
Intervention: Impaired glucose tolerance subjects (IGT, n = 30)
Number of subjects: 430

Group type: EXPERIMENTAL
Intervention: Normal subjects rendered mildly hyperglycemic by a 24-h glucose infusion (1 mg/kg/min for NDT and 2 mg/kg/min for IGT)
Number of subjects: 430
Study: 2905989

Group type: EXPERIMENTAL
Intervention: Pindolol
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 14

Group type: COMPARATOR
Intervention: Propranolol
Number of subjects: 14
Study: 30304047

Group type: EXPERIMENTAL
Intervention: Unilateral (right side) stimulation of the HT7 acupuncture point using a single‐twitch electrical stimulus (1 Hz, 50 mA) throughout the surgery
Number of subjects: 100

Group type: COMPARATOR
Intervention: Electrodes alone attached to the HT7 point on the right side; no electrical stimulus applied (control group)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Unilateral (right side) stimulation of the HT7 acupuncture point
Number of subjects: 100
Study: 28856359

Group type: EXPERIMENTAL
Intervention: Anterior CSI
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Posterior CSI
Number of subjects: 55
Study: 26111250

Group type: EXPERIMENTAL
Intervention: Abandonment psychotherapy delivered by certified psychotherapists
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: Abandonment psychotherapy delivered by nurses
Number of subjects: 170

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 170
Study: 23710960

Group type: EXPERIMENTAL
Intervention: Hyaluronic acid (HA)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Saline group
Number of subjects: 57
Study: 21838913

Group type: EXPERIMENTAL
Intervention: Selenium micronutrient supplement
Number of subjects: 300

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 300
Study: 19531090

Group type: EXPERIMENTAL
Intervention: Colgate Sensitive Multi Protection toothpaste (C)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Sensodyne Total Protection (S)
Number of subjects: 34
Study: 17543818

Group type: EXPERIMENTAL
Intervention: Epidural analgesia with bupivacaine/fentanyl
Number of subjects: 10

Group type: COMPARATOR
Intervention: Intravenous morphine (patient-controlled analgesia)
Number of subjects: 10
Study: 15294856

Group type: EXPERIMENTAL
Intervention: Intervention group (screening and treatment for infection)
Number of subjects: 4429

Group type: COMPARATOR
Intervention: Control group (no screening revealed to caregivers)
Number of subjects: 4429

Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 4429

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 4429
Study: 11433674

Group type: EXPERIMENTAL
Intervention: Symptomatic epileptics
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Patients without detectable brain lesions
Number of subjects: 108

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 108
Study: 9602986

Group type: EXPERIMENTAL
Intervention: Ranitidine (300 mg daily, at night)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Sucralfate (2 g twice daily)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 24
Study: 7599759

Group type: EXPERIMENTAL
Intervention: cilazapril
Number of subjects: 257

Group type: COMPARATOR
Intervention: atenolol
Number of subjects: 257
Study: 2403809

Group type: EXPERIMENTAL
Intervention: Surgery and steroids
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control or comparison group
Number of subjects: 0
Study: 359215

Group type: EXPERIMENTAL
Intervention: Trimazosin 100 to 300 mg
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 31804894

Group type: EXPERIMENTAL
Intervention: Capecitabine
Number of subjects: 876

Group type: COMPARATOR
Intervention: Observation
Number of subjects: 876

Group type: EXPERIMENTAL
Intervention: Capecitabine (nonbasal phenotype)
Number of subjects: 876

Group type: EXPERIMENTAL
Intervention: Capecitabine (basal phenotype)
Number of subjects: 876

Group type: EXPERIMENTAL
Intervention: Capecitabine (overall survival)
Number of subjects: 876
Study: 31219721

Group type: EXPERIMENTAL
Intervention: Nutri-Score
Number of subjects: 2907

Group type: COMPARATOR
Intervention: Reference Intakes
Number of subjects: 2907

Group type: COMPARATOR
Intervention: No label
Number of subjects: 2907
Study: 28719285

Group type: EXPERIMENTAL
Intervention: Novel intervention package delivered over 3 months including local rallies, games, rewards, storytelling, drama, competitions, and kitchen makeovers.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (four villages) with no intervention.
Number of subjects: 0
Study: 26581750

Group type: EXPERIMENTAL
Intervention: High-dose esomeprazole (80 mg + 8 mg/h)
Number of subjects: 215

Group type: COMPARATOR
Intervention: Cimetidine (200 mg + 60 mg/h)
Number of subjects: 215
Study: 24232362

Group type: EXPERIMENTAL
Intervention: Structured exercise program (weekly supervised gym sessions of stationary cycling and resistance exercises, and a twice weekly independent home-based walking program)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Structured exercise program
Number of subjects: 31

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 31
Study: 20521029

Group type: EXPERIMENTAL
Intervention: Positive parenting
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Recent negative life events
Number of subjects: 55

Group type: COMPARATOR
Intervention: Current internalizing and externalizing symptoms
Number of subjects: 55
Study: 19274317

Group type: EXPERIMENTAL
Intervention: Weekly doses of 25 mg of elemental iron administered at home
Number of subjects: 130

Group type: COMPARATOR
Intervention: Weekly doses of 25 mg of elemental iron administered in healthcare clinic
Number of subjects: 130
Study: 16996948

Group type: EXPERIMENTAL
Intervention: OPCAB
Number of subjects: 100

Group type: COMPARATOR
Intervention: ONCAB
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 100
Study: 14535968

Group type: EXPERIMENTAL
Intervention: Hyperglycaemia (15 mmol L(‐1))
Number of subjects: 18
Study: 11094802

Group type: EXPERIMENTAL
Intervention: Hamming clustering (HC)
Number of subjects: 115

Group type: COMPARATOR
Intervention: Standard classifiers
Number of subjects: 115
Study: 2029860

Group type: COMPARATOR
Intervention: Tramadol 75 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Tramadol 150 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tramadol 300 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Morphine 15 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Morphine 30 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 7204788

Group type: EXPERIMENTAL
Intervention: Methacholine
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Ragweed
Number of subjects: 7
Study: 30865796

Group type: EXPERIMENTAL
Intervention: Bempedoic acid
Number of subjects: 2230

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2230
Study: 28803797

Group type: COMPARATOR
Intervention: Hot conditions (35°C/40%rH)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Temperate conditions (24°C/30%rH)
Number of subjects: 10
Study: 27812636

Group type: EXPERIMENTAL
Intervention: Gel pillow with side cutouts
Number of subjects: 23

Group type: COMPARATOR
Intervention: Control pillow (own pillow)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Foam pillow
Number of subjects: 23
Study: 24440576

Group type: EXPERIMENTAL
Intervention: Attempts to control worry
Number of subjects: 0

Group type: COMPARATOR
Intervention: Attempts to control neutral thought
Number of subjects: 0

Group type: COMPARATOR
Intervention: Subset of participants without instructions to control thoughts
Number of subjects: 0
Study: 22149291

Group type: EXPERIMENTAL
Intervention: Mental contrasting
Number of subjects: 134

Group type: COMPARATOR
Intervention: Indulging
Number of subjects: 134

Group type: COMPARATOR
Intervention: Control
Number of subjects: 134
Study: 20399363

Group type: EXPERIMENTAL
Intervention: Reamed intramedullary nailing
Number of subjects: 0

Group type: COMPARATOR
Intervention: Unreamed intramedullary nailing
Number of subjects: 0
Study: 17379047

Group type: EXPERIMENTAL
Intervention: VAL/HCTZ 320/25 mg
Number of subjects: 1346

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1346

Group type: COMPARATOR
Intervention: HCTZ monotherapies
Number of subjects: 1346

Group type: EXPERIMENTAL
Intervention: VAL/HCTZ combinations
Number of subjects: 1346
Study: 16270637

Group type: EXPERIMENTAL
Intervention: Ximelagatran 24 mg twice daily
Number of subjects: 1223

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1223
Study: 11888606

Group type: EXPERIMENTAL
Intervention: Randomised participants
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Secondary analyses (per-protocol or as-treated participants)
Number of subjects: 0
Study: 10190880

Group type: EXPERIMENTAL
Intervention: Standing position
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Tyramine administration
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Isoproterenol administration
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Phenylephrine administration
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Baroreflex sensitivity measurement
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Intrinsic heart rate measurement
Number of subjects: 13
Study: 7800313

Group type: EXPERIMENTAL
Intervention: Continuous electronic fetal heart rate monitoring (EFM)
Number of subjects: 18561
Study: 11527135

Group type: EXPERIMENTAL
Intervention: Atenolol (50 mg)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Bisoprolol (5 mg)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Atenolol and Bisoprolol (both beta1-selective beta-blockers)
Number of subjects: 40
Study: 6127907

Group type: EXPERIMENTAL
Intervention: Clorazepate
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Anti-anxiety drugs (including clorazepate and diazepam)
Number of subjects: 127

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Lorazepam plus bendrofluazide
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Bendrofluazide
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Lorazepam
Number of subjects: 127
Study: 31500444

Group type: EXPERIMENTAL
Intervention: Implantable cardioverter-defibrillator implantation
Number of subjects: 1116

Group type: COMPARATOR
Intervention: Control group (no implantable cardioverter-defibrillator implantation)
Number of subjects: 1116